• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗效力估计中的竞争异质性

Competing Heterogeneities in Vaccine Effectiveness Estimation.

作者信息

Nikas Ariel, Ahmed Hasan, Zarnitsyna Veronika I

机构信息

Emory University School of Medicine, Department of Microbiology and Immunology, Atlanta, Georgia, United States of America.

Emory University, Department of Biology, Atlanta, Georgia, United States of America.

出版信息

ArXiv. 2023 May 12:arXiv:2305.01737v2.

PMID:37205263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10187365/
Abstract

Understanding waning of vaccine-induced protection is important for both immunology and public health. Population heterogeneities in underlying (pre-vaccination) susceptibility and vaccine response can cause measured vaccine effectiveness (mVE) to change over time even in the absence of pathogen evolution and any actual waning of immune responses. We use a multi-scale agent-based models parameterized using epidemiological and immunological data, to investigate the effect of these heterogeneities on mVE as measured by the hazard ratio. Based on our previous work, we consider waning of antibodies according to a power law and link it to protection in two ways: 1) motivated by correlates of risk data and 2) using a within-host model of stochastic viral extinction. The effect of the heterogeneities is given by concise and understandable formulas, one of which is essentially a generalization of Fisher's fundamental theorem of natural selection to include higher derivatives. Heterogeneity in underlying susceptibility accelerates apparent waning, whereas heterogeneity in vaccine response slows down apparent waning. Our models suggest that heterogeneity in underlying susceptibility is likely to dominate. However, heterogeneity in vaccine response offsets <10% to >100% (median of 29%) of this effect in our simulations. Our methodology and results may be helpful in understanding competing heterogeneities and waning of immunity and vaccine-induced protection. Our study suggests heterogeneity is more likely to 'bias' mVE downwards towards faster waning of immunity but a subtle bias in the opposite direction is also plausible.

摘要

了解疫苗诱导的保护作用的减弱对于免疫学和公共卫生都很重要。潜在(接种疫苗前)易感性和疫苗反应中的人群异质性可能导致即使在病原体没有进化且免疫反应没有实际减弱的情况下,实测疫苗效力(mVE)也会随时间变化。我们使用基于多尺度主体的模型,通过流行病学和免疫学数据进行参数化,以研究这些异质性对通过风险比衡量的mVE的影响。基于我们之前的工作,我们根据幂律考虑抗体的减弱,并通过两种方式将其与保护作用联系起来:1)受风险数据相关性的推动;2)使用宿主内随机病毒灭绝模型。异质性的影响由简洁易懂的公式给出,其中一个公式本质上是对费希尔自然选择基本定理的推广,以纳入高阶导数。潜在易感性的异质性加速了明显的减弱,而疫苗反应的异质性减缓了明显的减弱。我们的模型表明,潜在易感性的异质性可能占主导。然而,在我们的模拟中,疫苗反应的异质性抵消了这种影响的10%以下至100%以上(中位数为29%)。我们的方法和结果可能有助于理解相互竞争的异质性以及免疫和疫苗诱导保护作用的减弱。我们的研究表明,异质性更有可能使mVE“偏向”免疫力更快减弱的方向,但相反方向的细微偏差也有可能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/89645b50f7a8/nihpp-2305.01737v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/0da9ef547f65/nihpp-2305.01737v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/4f4a3fa3c170/nihpp-2305.01737v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/3b3d218fcabb/nihpp-2305.01737v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/001785c75602/nihpp-2305.01737v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/89645b50f7a8/nihpp-2305.01737v2-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/0da9ef547f65/nihpp-2305.01737v2-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/4f4a3fa3c170/nihpp-2305.01737v2-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/3b3d218fcabb/nihpp-2305.01737v2-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/001785c75602/nihpp-2305.01737v2-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c43f/10187365/89645b50f7a8/nihpp-2305.01737v2-f0005.jpg

相似文献

1
Competing Heterogeneities in Vaccine Effectiveness Estimation.疫苗效力估计中的竞争异质性
ArXiv. 2023 May 12:arXiv:2305.01737v2.
2
Competing Heterogeneities in Vaccine Effectiveness Estimation.疫苗效力估计中的竞争异质性
Vaccines (Basel). 2023 Aug 1;11(8):1312. doi: 10.3390/vaccines11081312.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Waning of Measured Influenza Vaccine Effectiveness Over Time: The Potential Contribution of Leaky Vaccine Effect.随时间推移测量的流感疫苗效力下降:漏接疫苗效应的潜在贡献。
Clin Infect Dis. 2020 Dec 17;71(10):e633-e641. doi: 10.1093/cid/ciaa340.
5
Estimating Waning of Vaccine Effectiveness: A Simulation Study.估算疫苗效力衰减:一项模拟研究。
Clin Infect Dis. 2023 Feb 8;76(3):479-486. doi: 10.1093/cid/ciac725.
6
Immunological heterogeneity informs estimation of the durability of vaccine protection.免疫异质性为疫苗保护持久性的评估提供信息。
J R Soc Interface. 2022 May;19(190):20220070. doi: 10.1098/rsif.2022.0070. Epub 2022 May 25.
7
Estimation of waning vaccine effectiveness from population-level surveillance data in multi-variant epidemics.从多变异体流行疫情的人群水平监测数据估计疫苗效力衰减情况。
Epidemics. 2023 Dec;45:100726. doi: 10.1016/j.epidem.2023.100726. Epub 2023 Nov 4.
8
Epidemiologic effects of varicella vaccination.水痘疫苗的流行病学效应。
Infect Dis Clin North Am. 1996 Sep;10(3):631-55. doi: 10.1016/s0891-5520(05)70318-4.
9
Depletion-of-susceptibles bias in influenza vaccine waning studies: how to ensure robust results.流感疫苗效力衰减研究中的易感者缺失偏倚:如何确保可靠的结果。
Epidemiol Infect. 2019 Nov 27;147:e306. doi: 10.1017/S0950268819001961.
10
Durability of Immune Response After COVID-19 Booster Vaccination and Association With COVID-19 Omicron Infection.COVID-19 加强针接种后免疫反应的持久性及其与 COVID-19 奥密克戎感染的关联。
JAMA Netw Open. 2022 Sep 1;5(9):e2231778. doi: 10.1001/jamanetworkopen.2022.31778.

本文引用的文献

1
Estimating Waning of Vaccine Effectiveness: A Simulation Study.估算疫苗效力衰减:一项模拟研究。
Clin Infect Dis. 2023 Feb 8;76(3):479-486. doi: 10.1093/cid/ciac725.
2
Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold.个体对 SARS-CoV-2 的易感性或暴露程度的差异降低了群体免疫阈值。
J Theor Biol. 2022 May 7;540:111063. doi: 10.1016/j.jtbi.2022.111063. Epub 2022 Feb 18.
3
Identifying and Alleviating Bias Due to Differential Depletion of Susceptible People in Postmarketing Evaluations of COVID-19 Vaccines.
识别和减轻 COVID-19 疫苗上市后评估中因易感人群差异消耗导致的偏倚。
Am J Epidemiol. 2022 Mar 24;191(5):800-811. doi: 10.1093/aje/kwac015.
4
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person's infectiousness.SARS-CoV-2 感染的体内动力学及其与个体传染性的关系。
Proc Natl Acad Sci U S A. 2021 Dec 7;118(49). doi: 10.1073/pnas.2111477118.
5
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.中和抗体滴度作为预测对 SARS-CoV-2 变异体的保护作用以及加强免疫的影响的指标:一项荟萃分析。
Lancet Microbe. 2022 Jan;3(1):e52-e61. doi: 10.1016/S2666-5247(21)00267-6. Epub 2021 Nov 15.
6
Dynamics and turnover of memory CD8 T cell responses following yellow fever vaccination.黄热病疫苗接种后记忆 CD8 T 细胞应答的动力学和周转率。
PLoS Comput Biol. 2021 Oct 14;17(10):e1009468. doi: 10.1371/journal.pcbi.1009468. eCollection 2021 Oct.
7
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.卡塔尔:BNT162b2 疫苗对 SARS-CoV-2 感染的保护作用逐渐减弱。
N Engl J Med. 2021 Dec 9;385(24):e83. doi: 10.1056/NEJMoa2114114. Epub 2021 Oct 6.
8
Comparing statistical methods for detecting and estimating waning efficacy of rotavirus vaccines in developing countries.比较发展中国家检测和估计轮状病毒疫苗效力衰减的统计方法。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4632-4635. doi: 10.1080/21645515.2021.1968738. Epub 2021 Oct 6.
9
Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.在华盛顿金县,5-9 岁儿童接种 5 剂无细胞百白破疫苗后的保护持久性。
Vaccine. 2021 Oct 1;39(41):6144-6150. doi: 10.1016/j.vaccine.2021.08.070. Epub 2021 Sep 4.
10
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce.在高度接种疫苗的医疗系统工作人员中出现的新冠病毒感染复发现象。
N Engl J Med. 2021 Sep 30;385(14):1330-1332. doi: 10.1056/NEJMc2112981. Epub 2021 Sep 1.